Sign in

CIK 0000730272 · Large accelerated filer

REPLIGEN CORP

Sign in to watch
Ticker
RGEN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
042729386
Phone
7814499560
Business address
41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
  1. 424B3 Offering Prospectus
  2. UPLOAD Other SEC-generated Letter
  3. CORRESP Other Correspondence Between Filers and SEC Staff
  4. UPLOAD Other SEC-generated Letter
  5. UPLOAD Other SEC-generated Letter
  6. CORRESP Other Correspondence Between Filers and SEC Staff
  7. UPLOAD Other SEC-generated Letter
  8. 424B7 Offering Prospectus
  9. 424B5 Offering Prospectus
  10. 424B5 Offering Prospectus
  11. 424B5 Offering Prospectus
  12. 424B5 Offering Prospectus
  13. 424B5 Offering Prospectus
  14. 424B5 Offering Prospectus
  15. 424B5 Offering Prospectus
  16. 424B5 Offering Prospectus
  17. 424B5 Offering Prospectus
  18. 424B5 Offering Prospectus
  19. UPLOAD Other SEC-generated Letter
  20. CORRESP Other Correspondence Between Filers and SEC Staff

Page 1 of 3 · 58 filings